Aggrenox - 0597-0001-60 - (aspirin and dipyridamole)

Alphabetical Index


Drug Information of Aggrenox

Product NDC: 0597-0001
Proprietary Name: Aggrenox
Non Proprietary Name: aspirin and dipyridamole
Active Ingredient(s): 25; 200    mg/1; mg/1 & nbsp;   aspirin and dipyridamole
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Aggrenox

Product NDC: 0597-0001
Labeler Name: Boehringer Ingelheim Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020884
Marketing Category: NDA
Start Marketing Date: 19991219

Package Information of Aggrenox

Package NDC: 0597-0001-60
Package Description: 1 BOTTLE in 1 CARTON (0597-0001-60) > 60 CAPSULE in 1 BOTTLE

NDC Information of Aggrenox

NDC Code 0597-0001-60
Proprietary Name Aggrenox
Package Description 1 BOTTLE in 1 CARTON (0597-0001-60) > 60 CAPSULE in 1 BOTTLE
Product NDC 0597-0001
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name aspirin and dipyridamole
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 19991219
Marketing Category Name NDA
Labeler Name Boehringer Ingelheim Pharmaceuticals, Inc.
Substance Name ASPIRIN; DIPYRIDAMOLE
Strength Number 25; 200
Strength Unit mg/1; mg/1
Pharmaceutical Classes Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]

Complete Information of Aggrenox


General Information